Wegovy vs Zepbound
Semaglutide vs Tirzepatide · Comparison Guide
Quick Comparison
| Feature | Wegovy | Zepbound |
|---|---|---|
| Generic Name | Semaglutide | Tirzepatide |
| Manufacturer | Novo Nordisk | Eli Lilly |
| Drug Class | GLP-1 Receptor Agonist | GIP/GLP-1 Receptor Agonist |
| Shared Conditions | Chronic Weight Management | |
Key Differences: Wegovy vs Zepbound
Both are weekly injectable medications for chronic weight management. Zepbound (tirzepatide) activates both GIP and GLP-1 receptors; Wegovy (semaglutide) activates GLP-1 only. SURMOUNT-5 head-to-head trial showed Zepbound achieved greater average weight loss (~47 lbs vs ~29 lbs) over 72 weeks. Both carry thyroid C-cell tumor black box warnings. Insurance coverage and formulary placement vary significantly.
💊 Wegovy (Semaglutide)
- Class: GLP-1 Receptor Agonist
- Manufacturer: Novo Nordisk
- Full Wegovy information →
💊 Zepbound (Tirzepatide)
- Class: GIP/GLP-1 Receptor Agonist
- Manufacturer: Eli Lilly
- Full Zepbound information →
Both are weekly injectable medications for chronic weight management. Zepbound (tirzepatide) activates both GIP and GLP-1 receptors; Wegovy (semaglutide) activates GLP-1 only. SURMOUNT-5 head-to-head trial showed Zepbound achieved greater average weight loss (~47 lbs vs ~29 lbs) over 72 weeks. Both carry thyroid C-cell tumor black box warnings. Insurance coverage and formulary placement vary significantly.
Neither Wegovy nor Zepbound is universally better — the right choice depends on your specific condition, disease severity, insurance formulary, and health history. Your prescriber will determine which is most appropriate based on your clinical situation. BiologicHealthPlus carries both and can help you compare your coverage and costs for either medication.
Switching between biologics is common. Your prescriber will evaluate your current treatment response and determine if a switch is appropriate. BiologicHealthPlus can coordinate the transition including prior authorization for your new medication.
Both Wegovy and Zepbound are covered by most commercial insurance plans, Medicare Part D, and Medicaid with prior authorization. BiologicHealthPlus handles insurance verification and prior authorization for both medications at no charge. Most insured patients pay $0–$35/month through manufacturer copay programs.
Wegovy and Zepbound both have high cash list prices ($4,000–$9,000/month range) but most commercially insured patients pay $0–$35/month through manufacturer savings programs. BiologicHealthPlus automatically enrolls every patient in all available savings programs at no charge.
✅ BiologicHealthPlus Carries Both Wegovy and Zepbound
We handle insurance verification, prior authorization, copay enrollment, and free cold-chain delivery for both medications. Contact us and we'll help you understand your options and costs.
Medical Disclaimer: This comparison is for educational purposes only. The choice between Wegovy and Zepbound should be made by your healthcare provider based on your specific medical history, disease severity, and individual circumstances. Last updated: July 2026.